Indications and uses
Cleansing pads for the treatment of acne.
Cleansing pads for the treatment of acne.
Wipe the entire affected area with a pad one to three times daily Because excessive drying of the skin can occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a physician If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Drug Facts
Salicylic Acid USP, 2%
Acne medication
Cleansing pads for the treatment of acne.
Ammonium Hydroxide, Camellia Sinensis Leaf Extract, Disodium EDTA, Glycolic Acid, Hamamelis Virginiana (Witch Hazel) Water, Imidazolidinyl Urea, Polysorbate 20, Purified Water, Sodium Benzoate.
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51326-923-01 | Gly-Sal 2-2 Pads | 60 in 1 JAR | CLOTH | 60 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51326-923 | 51326-923-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| AMMONIA | 5138Q19F1X | IACT |
| GREEN TEA LEAF | W2ZU1RY8B0 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| GLYCOLIC ACID | 0WT12SX38S | IACT |
| HAMAMELIS VIRGINIANA TOP WATER | NT00Y05A2V | IACT |
| IMIDUREA | M629807ATL | IACT |
| POLYSORBATE 20 | 7T1F30V5YH | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| ZINC PIDOLATE | C32PQ86DH4 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gly-Sal 2-2 Pads | SALICYLIC ACID | Topiderm, Inc. | a92a9ffb-5c5b-43a4-b669-04667324920b | 2023-02-16 | Warnings | 51326-923-01 51326-923 51326092301 45299656-b734-4edb-a780-e99a5a333043 a92a9ffb-5c5b-43a4-b669-04667324920b |
Adverse event summaries are temporarily unavailable. Other product information remains available.